If you would like to receive the daily Market Report by email please fill out your name and email address in the sign-up form below and you will be added to our mailing list.
U.K. stocks opened higher on Monday, with energy
stocks surging amidst fears of a widening conflict in the Middle East. European stocks were mixed as signs of
escalating tensions in the Middle East offset hopes for more interest rate cuts
from the Federal Reserve this year.
U.S. Stocks Give Back Ground, after moving mostly
higher early in the session the major averages have pulled back well off their
highs of the session, with the S&P 500 dipping into negative territory. The
early strength on Wall Street partly reflected optimism ahead of the release of
earnings news from several major technology companies.
Microsoft (MSFT), Meta Platforms (META), Apple (AAPL) and
Amazon (AMZN) are among the companies due to report their quarterly results
this week.
Buying interest waned shortly after the start of trading,
however, as traders seemed reluctant to make significant moves ahead of the
Federal Reserve's monetary policy meeting this week.
Gold prices rose toward $2,400 per ounce on Monday as
tensions in the Middle East showed little sign of abating.
Oil prices were subdued on Monday, heading into this
week's meeting of the Organization of Petroleum Exporting Countries (OPEC) and
its allies. Prices were flat to slightly lower in European trade after falling
by 1.5 percent on Friday amid persistent concerns over top importer China.
In corporate news, Reckitt Benckiser was under
the cosh amid concerns about potential litigation, after a US jury found on
Friday that infant formula by Abbott Laboratories had caused a
girl to develop a dangerous bowel disease.
Abbott was ordered to pay $495m in damages. This consisted
of $95m compensatory damages and $400m punitive.
Dan Coatsworth, investment analyst at AJ Bell,
said: "Reckitt’s shares have been severely depressed since March as the
market worries about the scale of any potential liabilities if the company
loses legal battles around the safety of its baby formula.